Obermeyer Wood Investment Counsel Lllp lessened its position in shares of UnitedHealth Group (NYSE:UNH) by 2.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 184,091 shares of the healthcare conglomerate’s stock after selling 5,154 shares during the period. UnitedHealth Group comprises 3.5% of Obermeyer Wood Investment Counsel Lllp’s investment portfolio, making the stock its 11th biggest holding. Obermeyer Wood Investment Counsel Lllp’s holdings in UnitedHealth Group were worth $40,585,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Maverick Capital Ltd. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $4,048,000. Kingdon Capital Management L.L.C. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $13,841,000. Arrowstreet Capital Limited Partnership boosted its holdings in shares of UnitedHealth Group by 30.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,303,068 shares of the healthcare conglomerate’s stock valued at $241,615,000 after buying an additional 300,744 shares in the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of UnitedHealth Group by 3,881.4% in the 2nd quarter. Tower Research Capital LLC TRC now owns 6,211 shares of the healthcare conglomerate’s stock valued at $1,152,000 after buying an additional 6,055 shares in the last quarter. Finally, Coldstream Capital Management Inc. boosted its holdings in shares of UnitedHealth Group by 37.8% in the 2nd quarter. Coldstream Capital Management Inc. now owns 1,698 shares of the healthcare conglomerate’s stock valued at $315,000 after buying an additional 466 shares in the last quarter. Institutional investors own 86.80% of the company’s stock.
Shares of UnitedHealth Group stock opened at $221.90 on Thursday. The firm has a market cap of $215,527.55, a price-to-earnings ratio of 22.04, a PEG ratio of 1.30 and a beta of 0.77. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group has a one year low of $164.60 and a one year high of $250.79.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th were given a dividend of $0.75 per share. The ex-dividend date was Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a yield of 1.35%. UnitedHealth Group’s payout ratio is currently 29.79%.
In other news, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction on Monday, March 19th. The shares were sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the transaction, the director now directly owns 1,771,257 shares of the company’s stock, valued at approximately $397,399,220.52. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Larry C. Renfro sold 22,184 shares of the company’s stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the transaction, the insider now directly owns 173,229 shares in the company, valued at $39,659,047.26. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 77,015 shares of company stock worth $17,879,199. Corporate insiders own 0.89% of the company’s stock.
Several research firms recently commented on UNH. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 price target for the company in a research report on Tuesday, April 3rd. Deutsche Bank upped their price target on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Cantor Fitzgerald reiterated a “buy” rating and issued a $235.00 price target on shares of UnitedHealth Group in a research report on Tuesday, January 16th. BMO Capital Markets upped their price target on shares of UnitedHealth Group from $14.50 to $275.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th. Finally, Credit Suisse Group upped their price target on shares of UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $244.06.
WARNING: This piece was originally published by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://dakotafinancialnews.com/2018/04/12/obermeyer-wood-investment-counsel-lllp-has-40-59-million-holdings-in-unitedhealth-group-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.